Lawrence Atinsky - Net Worth and Insider Trading

Lawrence Atinsky Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lawrence Atinsky owns 5 companies in total, including Deerfield Healthcare Technology Acquisitions Corp (DFHTU) , DFP Healthcare Acquisitions Corp (DFPHU) , and Nuo Therapeutics Inc (AURX) among others .

Click here to see the complete history of Lawrence Atinsky’s form 4 insider trades.

Insider Ownership Summary of Lawrence Atinsky

Ticker	Comapny	Transaction Date	Type of Owner
DFHTU	Deerfield Healthcare Technology Acquisitions Corp	2020-07-16	director & 10 percent owner & Director by Deputization
DFPHU	DFP Healthcare Acquisitions Corp	2020-03-10	director & 10 percent owner & Director by Deputization
AURX	Nuo Therapeutics Inc	2018-12-31	director
		2020-03-10	director & 10 percent owner & Director by Deputization
		2020-07-16	director & 10 percent owner & Director by Deputization

Lawrence Atinsky Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lawrence Atinsky Ownership Network

Ownership Network List of Lawrence Atinsky

No Data

Ownership Network Relation of Lawrence Atinsky

Lawrence Atinsky Owned Company Details

What does Deerfield Healthcare Technology Acquisitions Corp do?

Who are the key executives at Deerfield Healthcare Technology Acquisitions Corp?

Lawrence Atinsky is the director & 10 percent owner & Director by Deputization of Deerfield Healthcare Technology Acquisitions Corp. Other key executives at Deerfield Healthcare Technology Acquisitions Corp include director & 10 percent owner & other: Director by Deputization Deerfield Management Company, L.p. (series C) , director & 10 percent owner & other: Director by Deputization Deerfield Mgmt L.p. , and director & 10 percent owner & other: Director by Deputization Deerfield Partners, L.p. .

Deerfield Healthcare Technology Acquisitions Corp (DFHTU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Deerfield Healthcare Technology Acquisitions Corp (DFHTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Deerfield Healthcare Technology Acquisitions Corp Insider Transactions

No Available Data

What does DFP Healthcare Acquisitions Corp do?

Who are the key executives at DFP Healthcare Acquisitions Corp?

Lawrence Atinsky is the director & 10 percent owner & Director by Deputization of DFP Healthcare Acquisitions Corp. Other key executives at DFP Healthcare Acquisitions Corp include director & 10 percent owner & other: Director by Deputization Deerfield Management Company, L.p. (series C) , director & 10 percent owner & other: Director by Deputization Deerfield Mgmt L.p. , and director & 10 percent owner & other: Director by Deputization Deerfield Partners, L.p. .

DFP Healthcare Acquisitions Corp (DFPHU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DFP Healthcare Acquisitions Corp (DFPHU)'s detailed insider trading history can be found in Insider Trading Tracker table.

DFP Healthcare Acquisitions Corp Insider Transactions

No Available Data

What does Nuo Therapeutics Inc do?

Who are the key executives at Nuo Therapeutics Inc?

Lawrence Atinsky is the director of Nuo Therapeutics Inc. Other key executives at Nuo Therapeutics Inc include 10 percent owner Charles E Sheedy , director & CEO & CFO David Emerson Jorden , and CSO Peter Clausen .

Nuo Therapeutics Inc (AURX) Insider Trades Summary

Over the past 18 months, Lawrence Atinsky made no insider transaction in Nuo Therapeutics Inc (AURX). Other recent insider transactions involving Nuo Therapeutics Inc (AURX) include a net purchase of 437,500 shares made by Charles E Sheedy ,

In summary, during the past 3 months, insiders sold 0 shares of Nuo Therapeutics Inc (AURX) in total and bought 125,000 shares, with a net purchase of 125,000 shares. During the past 18 months, 0 shares of Nuo Therapeutics Inc (AURX) were sold and 437,500 shares were bought by its insiders, resulting in a net purchase of 437,500 shares.

Nuo Therapeutics Inc (AURX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nuo Therapeutics Inc Insider Transactions

No Available Data

What does The Oncology Institute Inc do?

Who are the key executives at The Oncology Institute Inc?

Lawrence Atinsky is the director & 10 percent owner & Director by Deputization of The Oncology Institute Inc. Other key executives at The Oncology Institute Inc include 10 percent owner Havencrest Healthcare Partners, L.p. , Chief Financial Officer & other: Principal Financial Officer Mihir Shah , and director & Chief Executive Officer Brad Hively .

The Oncology Institute Inc (TOI) Insider Trades Summary

Over the past 18 months, Lawrence Atinsky made no insider transaction in The Oncology Institute Inc (TOI). Other recent insider transactions involving The Oncology Institute Inc (TOI) include a net sale of 80,000 shares made by Havencrest Healthcare Partners, L.p. , a net sale of 72,000 shares made by Brad Hively , and a net purchase of 100,000 shares made by Mihir Shah .

In summary, during the past 3 months, insiders sold 0 shares of The Oncology Institute Inc (TOI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 152,000 shares of The Oncology Institute Inc (TOI) were sold and 100,000 shares were bought by its insiders, resulting in a net sale of 52,000 shares.

The Oncology Institute Inc (TOI)'s detailed insider trading history can be found in Insider Trading Tracker table.

The Oncology Institute Inc Insider Transactions

No Available Data

What does CareMax Inc do?

Who are the key executives at CareMax Inc?

Lawrence Atinsky is the director & 10 percent owner & Director by Deputization of CareMax Inc. Other key executives at CareMax Inc include director & 10 percent owner De La Torre Ralph , EVP and COO Solo Alberto De , and director & President and CEO De Solo Carlos A. .

CareMax Inc (CMAX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CareMax Inc (CMAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CareMax Inc (CMAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CareMax Inc (CMAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

CareMax Inc Insider Transactions

No Available Data

Lawrence Atinsky Mailing Address

Above is the net worth, insider trading, and ownership report for Lawrence Atinsky. You might contact Lawrence Atinsky via mailing address: 780 Third Avenue, 37th Floor, New York Ny 10017.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.